Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/21/2025

Management of Atrial Flutter with Hyperthyroidism on Apixaban

Anticoagulation Recommendations

  • The American College of Cardiology recommends continuing apixaban at the current dose for stroke prevention in patients with atrial flutter and hyperthyroidism, as anticoagulation recommendations are identical to those for atrial fibrillation, guided by CHA₂DS₂-VASc score rather than thyroid status 1, 2, 3
  • The American College of Chest Physicians states that a patient's age (70s) alone gives a CHA₂DS₂-VASc score ≥2, mandating oral anticoagulation regardless of thyroid function 4
  • Anticoagulation should continue throughout hyperthyroidism treatment and after achieving euthyroid state, as stroke risk is determined by the CHA₂DS₂-VASc score, not thyroid status, according to the American College of Cardiology and European Heart Journal 1, 2, 5

Rate Control Recommendations

  • The American College of Cardiology and European Heart Journal recommend starting a beta-blocker immediately as first-line therapy for ventricular rate control in hyperthyroidism-related atrial flutter 1, 2, 5
  • Beta-blockers are a Class I recommendation (highest level) for rate control in thyrotoxicosis-associated atrial arrhythmias, providing dual benefit: controlling heart rate AND inhibiting peripheral conversion of T4 to T3, according to the American College of Cardiology and European Heart Journal 1, 2
  • If beta-blockers are contraindicated, non-dihydropyridine calcium channel blockers (diltiazem or verapamil) should be used as second-line agents, according to the American College of Cardiology and European Heart Journal 1, 2, 5

Treatment of Underlying Hyperthyroidism

  • The American College of Cardiology recommends not attempting rhythm control (cardioversion or antiarrhythmic drugs) until euthyroid state is achieved 5

Monitoring and Adjusting Anticoagulation Strategy

  • Once euthyroid state is restored, continue anticoagulation based on CHA₂DS₂-VASc score, not thyroid status, according to the American College of Cardiology and European Heart Journal 1, 2
  • If atrial flutter persists despite euthyroid state, consider catheter ablation of the cavotricuspid isthmus (CTI) as definitive therapy, according to Circulation 3

Critical Management Pitfalls to Avoid

  • The American College of Cardiology and European Heart Journal recommend not using digoxin as monotherapy for rate control in hyperthyroidism-related atrial flutter 1, 2